Table 1 Baseline clinical characteristics of all patients (n = 441)
From: Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment
Basal | |
|---|---|
Age (years) | 67.20 ± 0.50 |
Body mass index (kg/m2) | 24.55 ± 0.18 |
Serum calcium (mg/dl) | 9.36 ± 0.02 |
Urinary calcium (mg/24 h) | 171.30 ± 5.20 |
Serum phosphate (mg/dl) | 3.97 ± 0.03 |
25(OH) vitamin D (ng/ml) | 32.04 ± 1.00 |
iPTH (pg/ml) | 51.00 ± 3.11 |
tAP (IU/L) | 59.70 ± 1.36 |
BGP (ng/ml) | 17.02 ± 0.98 |
s-CTX (ng/l) | 331.10 ± 16.03 |
Lumbar spine BMD [g/cm2; T-score] | 0.859 ± 0.005; -2.75 ± 0.04 |
Femoral neck BMD [g/cm2; T-score] | 0.718 ± 0.004; -2.29 ± 0.04 |
Total hip BMD [g/cm2; T-score] | 0.747 ± 0.005; -2.17 ± 0.05 |